Alkermes (ALKS) Enterprise Value Growth (5y) (2015 - 2026)
Alkermes (ALKS) Enterprise Value Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.07 Bn | 7.42 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.05% |
| Mar 31, 2026 | 1.10% |
| Dec 31, 2025 | -12.01% |
| Sep 30, 2025 | -14.31% |
| Jun 30, 2025 | -13.78% |
| Mar 31, 2025 | -12.25% |
| Dec 31, 2024 | -7.04% |
| Sep 30, 2024 | -9.13% |
| Jun 30, 2024 | -8.97% |
| Mar 31, 2024 | -5.06% |
| Dec 31, 2023 | -7.48% |
| Sep 30, 2023 | -13.74% |
| Jun 30, 2023 | -13.85% |
| Mar 31, 2023 | -8.22% |
| Dec 31, 2022 | -7.02% |
| Sep 30, 2022 | -5.21% |
| Jun 30, 2022 | -4.11% |
| Mar 31, 2022 | -2.11% |
| Dec 31, 2021 | -1.52% |
| Sep 30, 2021 | -0.39% |